中航（成都）无人机系统股份有限公司 2025 年度提质增效重回报专项行动方案 半年度评估报告 公司董事会于 2025 年 3 月 28 日审议通过了 2025 年度"提质增效重回报" 行动方案（以下简称"行动方案"）。现将 2025 年上半年行动方案主要举措进 展及成效报告如下： 一、提升经营质量方面 2025 年上半年，公司锚定战略方向，以"提质增效"为核心目标，全力推 动经营目标按计划落地，各项关键指标呈现逐步回升态势。上半年实现营业收入 43,868.79 万元，同比增加 61.27%；实现归属于母公司所有者的净利润 3,177.33 万元，同比增加 182.76%；实现归属于母公司所有者的扣除非经常性损益的净利 润 2,194.58 万元，同比增加 142.96%。公司报告期末总资产 897,945.77 万元， 同比增长 2.87%；归属于母公司的所有者权益 572,232.69 万元，同比增长 0.64%。 公司积极把握国内外市场机遇，系统推进市场多元化布局。军贸市场方面， 持续加强国际交流活动，深挖客户需求，瞄准翼龙-X、翼龙-1G 等新产品、新市 场积极开拓。国内市场方面，在关键市场领域实现突 ...

二、监事会会议审议情况 经全体监事审议，形成决议如下： 证券代码：688297 证券简称：中无人机 公告编号：2025-032 中航（成都）无人机系统股份有限公司 第五届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 中航（成都）无人机系统股份有限公司（以下简称"公司"）第五届监事会 第十七次会议于 2025 年 8 月 28 日以现场会议的方式召开。会议通知于 2025 年 8 月 18 日以电子邮件形式送达公司全体监事。 监事会主席高嵩先生主持会议，会议应参加监事 3 名，实际参加监事 3 名。 会议的召集和召开及监事出席人数符合《中华人民共和国公司法》等法律、法规、 规范性文件和《中航（成都）无人机系统股份有限公司章程》的有关规定。 完整，不存在虚假记载、误导性陈述和重大遗漏，并对其内容的真实性、准确性、 完整性依法承担法律责任。 (一) 关于公司《2025 年半年度报告》及摘要的议案 监事会同意公司《2025 年半年度报告》及摘要。 表决情况：赞成票：3 票，反对票： ...

中信建投证券股份有限公司、中航证券有限公司 关于中航（成都）无人机系统股份有限公司 2025 年半年度持续督导跟踪报告 | 保荐机构名称：中信建投证券股份有 | 被保荐公司名称：中航（成都）无人机 | | --- | --- | | 限公司 | 系统股份有限公司 | | 保荐代表人姓名：刘佳奇 | 联系方式：010-86451482 号院 | | | 联系地址：北京市朝阳区景辉街 16 | | | 1 号楼 11 层 | | 保荐代表人姓名：刘先丰 | 联系方式：010-56051819 号院 | | | 联系地址：北京市朝阳区景辉街 16 | | | 1 号楼 11 层 | | 保荐机构名称：中航证券有限公司 | 被保荐公司名称：中航（成都）无人机 | | | 系统股份有限公司 | | 保荐代表人姓名：孙捷 | 联系方式：010-59562504 联系地址：北京市朝阳区望京东园四区 | | | 中航产融大厦 37 层 | | 保荐代表人姓名：申希强 | 联系方式：010-59562504 联系地址：北京市朝阳区望京东园四区 | | | 中航产融大厦 层 37 | 经中国证券监督管理委员会（简称"中国证监会" ...

中航（成都）无人机系统股份有限公司2025 年半年度报告 公司代码：688297 中航（成都）无人机系统股份有限公司 2025 年半年度报告 1 / 168 中航（成都）无人机系统股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中描述公司面临的风险，敬请查阅本报告"第三节管理层讨论与分析"之 "四、 风险因素"相关内容，请投资者予以关注。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告中涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺，敬请投资者 注意投资风险。 九、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 五、 公司负责人张晓军、主管会计工作负责人王飞及会计机构负责人（会计主管人员）张明朗 声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七 ...

Core Insights - The stock of Zhong Unmanned Aerial Vehicle (UAV) increased by 2.19% on August 28, with a trading volume of 896 million yuan [1] - The company reported a significant year-on-year revenue growth of 284.64% for the first quarter of 2025, reaching 236 million yuan [2] - The total dividends distributed by Zhong UAV since its A-share listing amount to 357 million yuan [3] Financing and Trading Activity - On August 28, Zhong UAV had a net financing buy of -7.73 million yuan, with a total financing balance of 636 million yuan, representing 1.62% of its market capitalization [1] - The company’s margin trading balance is at a high level, exceeding the 90th percentile of the past year [1] - The short selling activity on August 28 included 1,000 shares sold and 900 shares repaid, with a short selling balance of 432,230 yuan, also at a high level [1] Shareholder Structure - As of March 31, the number of shareholders for Zhong UAV decreased by 6.54% to 28,200, while the average number of circulating shares per person increased by 6.99% to 9,643 shares [2] - Major shareholders include various ETFs, with notable changes in holdings among the top ten shareholders [3]

Group 1 - Military stocks experienced a surge on August 20, with Zhongtian Rocket hitting the daily limit up [1] - AVIC Chengfei rose over 5%, indicating strong market interest in defense-related companies [1] - Other companies such as Hengyu Xintong, Chenxi Aviation, Beifang Changlong, Zhong Wulian, Hangfa Technology, and Aerospace Electronics also saw gains [1]

Core Insights - Six He Investment conducted a survey on a listed company, Anjisi, revealing confidence in annual targets despite a slight decline in North American sales due to US-China trade tariffs [1] - Anjisi's R&D expenses increased by 90.73% year-on-year, primarily for the development of Hang'an medical diagnostic equipment, with a soft endoscope entering the product registration phase [1] - Domestic sales revenue grew by 10.50%, although the gross margin decreased to 67.58% due to the impact of centralized procurement on hemostatic clips [1] Company Performance - Anjisi's ERCP product series is rapidly expanding, with single-pole ESD products trialed in over 250 hospitals and an admission rate of 20% [1] - The company's self-branded sales proportion is increasing, and it is collaborating with top KOLs in Europe and Asia-Pacific to deepen its global presence [1] - The Thai production base project is progressing steadily, with production costs higher than domestic levels, focusing on mid-to-low-end consumables [1] Regional Sales Insights - Sales revenue in Europe, Asia, and South America is growing, while North American sales are declining [1] - Multiple products are entering the product registration phase, indicating ongoing expansion efforts [1]

Market Overview - The main funds in the Shanghai and Shenzhen markets experienced a net outflow of 75.08 billion yuan, with the Sci-Tech Innovation Board seeing a net outflow of 3.46 billion yuan [1] - A total of 185 stocks saw net inflows, while 403 stocks experienced net outflows [1] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 73 stocks rose, with two stocks, Youfang Technology and Botao Biology, hitting the daily limit [1] - The stock with the highest net inflow was Haiguang Information, with a net inflow of 583.88 million yuan, followed by Hanwujing and Shenzhou Cell with net inflows of 388.54 million yuan and 155.52 million yuan respectively [1][2] Continuous Fund Flow - There are 30 stocks that have seen continuous net inflows for more than three trading days, with Dingyang Technology leading at 10 consecutive days of inflow [2] - Conversely, 164 stocks have experienced continuous net outflows, with Nami Technology leading at 12 consecutive days of outflow [2] Notable Stocks - The top stocks by net inflow include: - Haiguang Information: 583.39 million yuan, 4.85% inflow rate, 8.83% increase [2] - Hanwujing: 388.54 million yuan, 2.77% inflow rate, 10.35% increase [2] - Shenzhou Cell: 155.52 million yuan, 12.98% inflow rate, 5.21% increase [2] - The stocks with the highest net outflows include: - Shijia Photon: 353 million yuan, 8.30% decrease [1] - Changguang Huaxin: 157 million yuan outflow [1] - Zhong Wurenji: 142 million yuan outflow [1] Summary of Fund Flows - The overall trend indicates a significant outflow of funds from the market, particularly affecting the Sci-Tech Innovation Board, with a notable number of stocks experiencing continuous inflows and outflows [1][2]

Core Viewpoint - Zigong, a city with a rich history in salt production, is emerging as a significant player in the low-altitude economy, primarily driven by the development of the drone industry and supportive government policies [4][11][31]. Group 1: Industry Development - Zigong has established an industrial cluster in the drone sector, with over 60 key enterprises, including notable companies like Tengdun Technology and AVIC [4][14]. - The low-altitude economy in Zigong achieved a production value exceeding 10 billion yuan in 2023, with an additional 10 billion yuan in signed projects for 2024 [4][31]. - The city is strategically located near major urban centers like Chengdu and Chongqing, facilitating integration into the Chengdu-Chongqing economic circle [12][31]. Group 2: Historical Context - Zigong's industrial history began with salt production during the Eastern Han Dynasty, evolving into a chemical industry hub in the mid-20th century [7][9]. - The decline of traditional industries post-2000 prompted Zigong to seek new economic avenues, leading to the focus on low-altitude aviation [10][11]. Group 3: Government Support and Infrastructure - The local government has prioritized land allocation and infrastructure development for the low-altitude economy, including a 494 million yuan special bond for infrastructure projects [31]. - Zigong has established favorable tax incentives for aviation enterprises, with significant reductions in property and land taxes [31]. - The city has developed two general aviation airports, enhancing its capacity for drone testing and operations [20][22]. Group 4: Future Prospects - By 2027, Zigong aims to scale its low-altitude economy to 30 billion yuan, with plans to produce over 2,000 medium and large drones and attract more than 200 new enterprises [32][33]. - The long-term goal for 2035 is to achieve an industrial scale exceeding 100 billion yuan, positioning Zigong as a leader in the low-altitude economy and contributing to the transformation of traditional industrial cities [33].

来源：金融界 主力资金净流出居前的分别为安杰思（1536.17万元）、科华生物（1457.06万元）、海利生物（1440.72 万元）、华大基因（1419.47万元）、福瑞股份（1329.15万元）。 序号代码名称最新价涨跌幅主力净流入主力净占比1300760迈瑞医疗230.5-0.098724.29万元 6.07%2300753爱朋医疗34.261.935531.45万元7.53%3300314戴维医疗15.2510.035504.85万元 11.77%4603658安图生物42.343.394457.47万元15.08%5688273麦澜德44.759.234025.59万元9.14%6002432 九安医疗40.121.192866.50万元6.27%7600587新华医疗18.144.432682.44万元3.88%8300453三鑫医疗 9.413.982472.80万元10.27%9688271联影医疗130.68-0.021943.47万元5.25%10603309维力医疗 14.92.831756.01万元10.29% 8月11日，医疗器械行业上涨1.65%，今日主力资金流出4.97亿元，成分 ...